Kimberly-Clark Announces Year-End 2009 Results and 2010 Outlook


    
    4Q Net Sales Increased 8 Percent to $5.0 Billion; EPS of $1.17 Up 16
    Percent

    4Q Cash Provided By Operations Rose 48 Percent to $1.0 Billion

    Company Resuming Share Repurchases and Planning For High Single-Digit to
    Low Double-Digit Increase in 2010 Dividend

    2010 Adjusted EPS Guidance $4.80 to $5.00, Up 6 to 11 Percent Versus 2009
    EPS, In Line With or Slightly Above Long-Term Target

    Company Reaffirms Top- and Bottom-Line Growth Objectives Through 2015









    
</pre>
<p><location>DALLAS</location>, <chron>Jan. 22</chron> /CNW/ -- Kimberly-Clark Corporation (NYSE:   KMB) today reported that net sales in the fourth quarter of 2009 increased 8.4 percent to <money>$5.0 billion</money>, including an approximate 5 percent benefit from stronger foreign currency exchange rates.  Organic sales rose nearly 3 percent, driven by higher sales volumes of about 2 percent and increased net selling prices of approximately 2 percent, while changes in product mix were unfavorable by about 1 percent.  The combined impact of the I-Flow Corporation and <location>Jackson</location> Safety acquisitions added an additional point of sales growth in the quarter.  The organic sales growth was highlighted by double-digit increases for the company's global Health Care business and for K-C's international operations in Asia, Latin America, the <location>Middle East</location>, Eastern <location>Europe</location> and <location>Africa</location>.</p>
<p/>
<p>Diluted net income per share for the quarter was <money>$1.17</money> compared with <money>$1.01</money> in 2008.  The bottom-line improvement was driven by a 15 percent increase in operating profit.  In addition, earnings per share growth benefited from higher income at the company's equity affiliate, Kimberly-Clark de <location>Mexico</location>, partially offset by a higher effective tax rate.  Fourth quarter gross profit margin increased by 180 basis points compared to the year-ago period, including benefits from higher selling prices, input cost deflation and cost reduction efforts, while the growth in operating profit was achieved despite an increase in strategic marketing spending of about <money>$45 million</money> in local currency terms.  For the full year 2009, diluted net income per share was <money>$4.52</money> compared to the company's previous guidance of <money>$4.50 to $4.60</money>.  For the full year 2008, diluted net income per share and adjusted earnings per share were <money>$4.03</money> and <money>$4.13</money>, respectively.</p>
<p/>
<p>Adjusted earnings per share in 2008 exclude charges for strategic cost reductions and an extraordinary loss.  Additional detail on these items and further information about adjusted earnings per share and why the company uses this non-GAAP financial measure are provided later in this news release.</p>
<p/>
<p>Chairman and Chief Executive Officer Thomas J. Falk said, "Our fourth quarter results completed a strong year for Kimberly-Clark.  In 2009 we delivered excellent performance in the near-term while we maintained our strong focus on doing what's right for sustainable, long-term growth.  Despite the difficult environment, we grew organic sales by about 3 percent in 2009.  At the same time, we aggressively reduced costs, significantly improved profitability and delivered all-time record cash flow.  In addition, we increased strategic marketing spending by about <money>$140 million</money> in local currency terms and strengthened our brands with meaningful innovations.  We also continued to make progress with our targeted growth initiatives, particularly in our K-C International business and in higher-margin, higher-growth opportunities in K-C Professional and Health Care.  All-in-all, we executed our business plans well and achieved growth in earnings per share of 9 percent in 2009 compared to adjusted results in 2008.  That's at the high end of our long-term target and is a terrific accomplishment by K-C's worldwide team."</p>
<pre>
    

    Review of fourth quarter sales by business segment

    
</pre>
<p>Sales of personal care products increased 11.5 percent compared with the fourth quarter of 2008. Sales volumes rose 5 percent, changes in currency rates added another 5 points to sales, and higher net selling prices contributed 2 points of growth in the quarter, while product mix was off 1 percent.</p>
<p/>
<p>Personal care sales in <location>North America</location> increased nearly 1 percent versus the fourth quarter of 2008.  Sales volumes advanced more than 3 percent and currency effects added an additional point of growth, while net selling prices fell approximately 3 percent due to increased promotional activity.  Sales volumes for Huggies diapers rose 6 percent and market shares improved by approximately 1 percent.  Year-ago results for Huggies diapers were negatively impacted by customer inventory adjustments and increased consumer demand for lower-priced offerings.  In other areas of the business, sales volumes for K-C's adult incontinence brands rose 10 percent, with continued benefits from product innovation on the Depend brand launched earlier in the year, and volumes for Kotex feminine care products increased 11 percent, in part due to promotional activity.</p>
<p/>
<p>In <location>Europe</location>, personal care sales rose 10 percent in the quarter, including a currency exchange rate benefit of nearly 8 percent.  Sales volumes rose about 4 percent, while changes in product mix reduced sales by 1 percent.  The volume gains reflect continued strong performance for Huggies diapers in Central <location>Europe</location>, along with improvement in the company's four core markets of the U.K., <location>France</location>, <location>Italy</location> and <location>Spain</location>.  In addition, sales volumes for Huggies baby wipes increased at a double-digit rate in the fourth quarter.</p>
<p/>
<p>In K-C's international operations in Asia, Latin America, the <location>Middle East</location>, Eastern <location>Europe</location> and <location>Africa</location>, personal care sales increased 25 percent, as organic sales rose 15 percent and changes in currency rates added 10 points of top-line growth.  Net selling prices improved 9 percent and sales volumes advanced 7 percent in the fourth quarter, while changes in product mix reduced sales by about 1 percent.  The growth in organic sales was broad-based, with particular strength in <location>Argentina</location>, <location>Brazil</location>, <location>China</location>, <location>Israel</location>, <location>Russia</location>, and the Andean region in Latin America.</p>
<p/>
<p>Sales of consumer tissue products increased 0.9 percent in the fourth quarter.  Although favorable currency exchange rates improved sales by 4 percent, sales volumes were down 2 percent and net selling prices were lower by about 1 percent.</p>
<p/>
<p>In <location>North America</location>, sales of consumer tissue products decreased nearly 6 percent compared to the year-ago period.  Net selling prices fell 3 percent, due to an increase in competitive promotional activity, and sales volumes and changes in product mix each reduced sales by more than 1 point.  Sales volumes for Kleenex facial tissue rose 7 percent in the quarter, with increased promotional shipments and a modest benefit from the cold and flu season.  Paper towel volumes fell at a double-digit rate and continue to be impacted by consumer trade-down, while volumes for bathroom tissue fell slightly in the fourth quarter.</p>
<p/>
<p>In <location>Europe</location>, consumer tissue sales rose more than 1 percent compared with the fourth quarter of 2008, including favorable currency effects of 7 percent.  Net selling prices decreased 4 percent, reflecting a continued competitive environment, and sales volumes and product mix were each off about 1 percent in the quarter.</p>
<p/>
<p>In K-C's international operations in Asia, Latin America, the <location>Middle East</location>, Eastern <location>Europe</location> and <location>Africa</location>, consumer tissue sales increased about 13 percent, as currency effects were favorable by 10 percent and organic sales rose more than 2 percent.  Net selling prices increased 6 percent and product mix improved 1 percent in the quarter, reflecting the company's actions to improve net realized revenue.  These factors were partially offset by lower sales volumes of about 4 percent.</p>
<p/>
<p>Sales of K-C Professional (KCP) & other products increased 11.6 percent compared with the fourth quarter of 2008.  Net selling prices rose 7 percent, favorable currency effects benefited sales by 5 percent and the acquisition of <location>Jackson</location> Safety that occurred in <chron>April 2009</chron> added more than 3 points of sales growth in the quarter, while organic sales volumes fell about 3 percent.</p>
<p/>
<p>Economic weakness and high unemployment levels in <location>North America</location> and <location>Europe</location> continued to affect KCP's categories in the fourth quarter.  In <location>North America</location>, sales increased 4 percent, including an approximate 6 percent benefit from <location>Jackson</location> Safety.  Organic sales volumes were down about 5 percent, partially offset by higher net selling prices of about 3 percent.  In <location>Europe</location>, KCP's sales rose 6 percent in the fourth quarter, including favorable currency effects of more than 7 percent and a benefit from <location>Jackson</location> Safety of more than 1 percent.  Organic sales volumes were down about 4 percent, while net selling prices increased 1 percent.</p>
<p/>
<p>In K-C's international operations in Asia, Latin America, the <location>Middle East</location>, Eastern <location>Europe</location> and <location>Africa</location>, KCP's sales increased 34 percent, including benefits from currency rates totaling nearly 15 percent.  Net selling prices improved more than 20 percent in the quarter, while sales volumes and changes in product mix were each down slightly.</p>
<p/>
<p>Sales of health care products increased 22.1 percent in the fourth quarter.  Growth was driven by a 13 percent increase in organic sales volumes and a 6 percent benefit from the acquisition of I-Flow Corporation, which closed in late <chron>November 2009</chron>.  In addition, favorable currency exchange rates added 3 points of sales growth in the quarter, while net selling prices and product mix were even with the prior year.  Organic volume growth was broad-based across several product categories, including continued double-digit growth in exam gloves and apparel.  The business continues to benefit from strong results in nitrile gloves, including the new Lavender offering introduced in late 2008.  In addition, increased global demand for face masks as a result of the H1N1 flu virus was responsible for approximately 6 points of organic volume growth in the quarter.</p>
<pre>
    

    Other fourth quarter operating results

    
</pre>
<p>Operating profit was <money>$717 million</money> in the fourth quarter of 2009, up 15 percent from <money>$623 million</money> in 2008, and up 14 percent compared with prior year adjusted operating profit of <money>$629 million</money>.  The latter amount excludes net charges incurred in 2008 for the company's strategic cost reduction plan.</p>
<p/>
<p>The improved results included the benefits of organic top-line growth, input cost deflation and cost savings.  Deflation in key cost inputs amounted to about <money>$145 million</money> overall versus 2008, including about <money>$50 million</money> in lower fiber costs, approximately <money>$50 million</money> for raw materials other than fiber, primarily polymer resins and other oil-based materials, about <money>$30 million</money> of lower energy costs, and <money>$15 million</money> in distribution costs.  Cost savings in the quarter from the company's FORCE (Focused On Reducing Costs Everywhere) program and strategic cost reduction plan totaled <money>$45 million</money> and <money>$7 million</money>, respectively.  Pension expense rose by about <money>$30 million</money>, with a majority of the increase reflected in cost of sales, and marketing, research and general expenses also increased, reflecting the previously mentioned rise in strategic marketing, along with higher selling and administrative expenses.</p>
<p/>
<p>The overall currency effect on fourth quarter operating profit was essentially neutral in the fourth quarter in 2009 versus 2008.  Translation gains totaled about <money>$15 million</money> and currency transaction losses included in other (income) and expense, net were <money>$1 million</money> in 2009 compared to <money>$20 million</money> in 2008.  These impacts were offset by about <money>$35 million</money> of expense in cost of sales in the fourth quarter of 2009 to recognize the U.S. dollar cost of importing finished product into <location>Venezuela</location> at the parallel market currency rate rather than the official rate.</p>
<p/>
<p>Other (income) and expense, net was <money>$25 million</money> of income in the fourth quarter of 2009 compared to <money>$15 million</money> of expense in the fourth quarter of 2008 which included a <money>$14 million</money> restructuring-related gain.  In addition to the lower level of currency transaction losses in 2009, the year-on-year improvement in other (income) and expense, net was driven by favorable settlement of value-added tax matters in Latin America in 2009, along with costs incurred in 2008 related to a legal judgment.</p>
<p/>
<p>The company's effective tax rate for the fourth quarter of 2009 was 28.0 percent, decreasing earnings by about 8 cents per share compared to 2008 adjusted results.  In the year-ago quarter, the effective tax rate was 22.4 percent and the adjusted effective tax rate, excluding the effects of charges for the company's strategic cost reduction plan, was 23.2 percent and included benefits from a number of tax matters.  For the full-year 2009, the company's effective tax rate was 29.0 percent, consistent with the company's previous estimate of 28 to 30 percent.  A reconciliation of the 2008 effective tax rate calculation is provided in a separate section of this news release.</p>
<p/>
<p>Kimberly-Clark's share of net income of equity companies in the fourth quarter increased to <money>$48 million</money> from <money>$21 million</money> in 2008, mainly as a result of higher net income at Kimberly-Clark de <location>Mexico</location>, S.A.B. de C.V. (KCM).  Prior-year results at KCM were negatively impacted by significant currency transaction losses on U.S. dollar-denominated liabilities, which reduced Kimberly-Clark's net income by approximately 6 cents per share in 2008.  In addition, KCM delivered solid organic sales growth and improved gross profit in the fourth quarter of 2009.</p>
<p/>
<p>Net income attributable to noncontrolling interests was <money>$30 million</money> in the fourth quarter of 2009 compared with <money>$35 million</money> in the prior year.  The decrease was primarily due to the acquisition of the remaining interest in the company's Andean affiliate in <chron>January 2009</chron>.</p>
<pre>
    

    Organization optimization initiative - update

    
</pre>
<p>As announced in June of 2009, the company initiated a plan to reduce its worldwide salaried workforce by approximately 1,600 positions by the end of 2009.  This action was intended to further improve Kimberly-Clark's underlying profitability and cash flow and put the company in a better position to take advantage of future growth and innovation opportunities.  Fourth quarter 2009 results included <money>$6 million</money> in pre-tax severance and related costs for this initiative, bringing full-year costs to <money>$128 million</money>.  A breakdown of the costs by income statement line and business segment is included later in this news release.  Related savings from this initiative were approximately <money>$30 million</money> in the fourth quarter of 2009 and <money>$55 million</money> for the full year.  Expected annualized pre-tax savings remain approximately <money>$135 million</money>.</p>
<pre>
    

    Cash flow and balance sheet

    
</pre>
<p>Cash provided by operations in the fourth quarter of 2009 totaled <money>$1,001 million</money>, an increase of 48 percent from <money>$678 million</money> in the prior year.  The improvement was driven by higher cash earnings and reduced working capital, partially offset by increased pension plan contributions.  Fourth quarter contributions to the company's defined benefit pension plans totaled <money>$127 million</money> in 2009 versus <money>$62 million</money> in 2008, bringing full year contributions to <money>$845 million</money> compared to <money>$129 million</money> in the prior year.  The company contributed <money>$100 million</money> to its U.S. defined benefit pension plan in the fourth quarter, which was incremental to the company's previous plan for the year.  Full year 2009 cash provided by operations was an all-time record of <money>$3,481 million</money>, up 38 percent from <money>$2,516 million</money> in 2008.</p>
<p/>
<p>Capital spending for the quarter was <money>$285 million</money> compared with <money>$253 million</money> in 2008.  For the full year of 2009, capital spending totaled <money>$848 million</money>, in line with the company's targeted range of <money>$800 to $850 million</money>.  Consistent with its previously announced plans for 2009, the company did not repurchase any shares of its common stock during the fourth quarter.  Total debt and redeemable securities was <money>$6.5 billion</money> at <chron>December 31, 2009</chron> compared with <money>$7.0 billion</money> at the end of 2008.</p>
<pre>
    

    Full year results

    
</pre>
<p>For the year of 2009, sales of <money>$19.1 billion</money> fell 1.5 percent from <money>$19.4 billion</money> in 2008, including unfavorable currency effects of about 5 percent.  Net selling prices increased nearly 4 percent, while organic sales volumes declined about 1 percent.  Full year operating profit of <money>$2,825 million</money> was up 11 percent compared to <money>$2,547 million</money> in 2008 and up 8 percent compared to 2008 adjusted operating profit of <money>$2,607 million</money>.  The benefits of organic sales growth, FORCE and strategic cost reduction plan savings of about <money>$240 million</money> and deflation in key cost components totaling approximately <money>$675 million</money>, were partially offset by negative currency effects of about <money>$355 million</money>, severance and related costs of <money>$128 million</money>, increased pension expense of about <money>$155 million</money>, higher operating costs and increased strategic marketing spending.  Diluted net income per share in 2009 was <money>$4.52</money> compared with <money>$4.03</money> in 2008 and 2008 adjusted earnings of <money>$4.13</money>.  Adjusted results in 2008 exclude strategic cost reduction charges and an extraordinary loss related to the restructuring of certain contractual arrangements.</p>
<pre>
    

    Outlook

    The company's key planning and guidance assumptions for 2010 are as
follows:

    --  Net sales increase of 5 to 6 percent.
        --  Organic sales are expected to grow 2 to 3 percent, driven by
volume
            growth of 2 to 3 percent.  Net selling prices and product mix are
            anticipated to be even with the prior year.
        --  The combined impact of the 2009 acquisitions of I-Flow Corporation
            and Jackson Safety should benefit 2010 sales by 1 point.
        --  Currency rates are expected to increase sales by approximately 2
            percent.  This assumes that rates are generally consistent with
            fourth quarter 2009 levels with the exception of the Venezuelan
            bolivar.  Following the recent devaluation of the bolivar, the
            company continues to evaluate the rate at which local currency
            results in Venezuela will be translated into U.S. dollars in 2010,
            but for current planning purposes has assumed a rate between 4.3
            and 6.0 bolivars to the U.S. dollar.  In 2009, about 3 percent of
            K-C net sales were generated in Venezuela.
    --  Adjusted operating profit growth of 7 to 11 percent.
        --  Inflation in key cost inputs of $300 to $400 million.  This
            reflects estimated average market pricing for benchmark northern
            softwood pulp of approximately $850 to $875 per metric ton and oil
            prices averaging $80 to $85 per barrel for the year.
        --  Savings from the company's FORCE program totaling $150 to $200
            million.
        --  Before any impact from the bolivar devaluation in Venezuela,
            year-over-year currency translation benefits of $85 to $115
million
            due to the strengthening of key foreign currencies versus the U.S.
            dollar.
        --  Pension expense of approximately $160 million across all company
            defined benefit plans, a decrease of approximately $90 million
from
            2009.  Cash contributions to the plans in 2010 are expected to
            total about $240 million versus $845 million in 2009.
        --  Strategic marketing spending is planned to increase faster than
            sales, supporting new and improved products, targeted growth
            initiatives and overall brand equity.
    --  The adjusted effective tax rate for the year is expected to be in a
        range of 29 to 31 percent compared to the 2009 effective rate of 29
        percent.  The year-over-year increase at the midpoint is equivalent to
        an approximate 1 1/2 point reduction in earnings growth.
    --  The company's share of net income of equity companies is expected to
        rise modestly compared to 2009's level, due to improved performance at
        K-C de Mexico.
    --  Capital spending should total $1.0 to $1.1 billion, in the lower half
        of the company's long-term targeted range of 5 to 6 percent of net
        sales.
    --  A high single-digit to low double-digit increase in the dividend is
        anticipated effective April 2010, subject to approval by the Board of
        Directors.
    --  Share repurchases are expected to total $500 to $600 million, subject
        to market conditions.  The company plans to begin repurchasing shares
        in the first quarter of 2010.
    --  The company will begin accounting for Venezuela as hyper-inflationary
        effective January 1, 2010 and currently anticipates recording a
        one-time after tax loss of $60 to $90 million (14 to 22 cents per
        share) in the first quarter for the expected remeasurement of the
local
        currency balance sheet in Venezuela as a result of the recent currency
        devaluation.  K-C's 2010 guidance for adjusted operating profit
growth,
        the adjusted effective tax rate and adjusted earnings per share
        excludes the impact of this loss and the company plans to report
        adjusted results in 2010 that will exclude the impact of this item.
    --  The company currently estimates that the ongoing impact of the January
        2010 currency devaluation in Venezuela will not materially impact the
        company's 2010 earnings per share.


    
</pre>
<p>Commenting on the outlook, Falk said, "The strength of our performance in 2009 gives us confidence that we will continue to execute our Global Business Plan well in the coming year.  We are planning for a slow and modest economic recovery in 2010, and as a result, organic sales volumes are expected to grow 2 to 3 percent after being down slightly in 2009.  We will continue to further strengthen our brands, pursue our targeted growth initiatives and reinvest for long-term success.  We have a healthy pipeline of innovation coming to market this year, and we will support our new and improved products with increased marketing spending. We will also invest more to further strengthen our research and customer development capabilities to improve our future growth prospects.  At the same time, we will remain focused on aggressively reducing costs and maximizing cash flow, which will help us overcome significant input cost inflation and enable our reinvestment plans.  All-in-all, we expect adjusted earnings per share in 2010 will be in a range of <money>$4.80 to $5.00</money> per share.  That's up 6 to 11 percent compared to 2009 earnings per share, in line with, or slightly above, our long-range Global Business Plan target.</p>
<p/>
<p>"Moreover, we will continue to deploy our cash flow in shareholder-friendly ways.  We anticipate a healthy increase in the dividend this year, enabling us to maintain our top-tier payout ratio.  In addition, because of our strong performance in 2009 and our confidence in our ability to generate strong cash flow going forward, we are resuming our share repurchase plan in 2010.</p>
<p/>
<p>"Lastly, we have recently completed a review of our long-range Global Business Plan and have further sharpened our strategies and plans to facilitate the delivery of our existing top- and bottom-line growth objectives through 2015.  Our annual growth targets remain 3 to 5 percent for net sales and mid- to high-single digits for earnings per share.  We will continue to pursue targeted growth initiatives and further develop the key capabilities necessary for sustainable growth.  At the same time, financial and cost discipline remain hallmarks of our Plan.  We will provide more details around our Global Business Plan 2015 at K-C's 2010 Investor Day, which will occur on <chron>Monday, March 22</chron> in <location>New York City</location>."</p>
<pre>
    

    Non-GAAP financial measures

    
</pre>
<p>This press release and the accompanying tables include the following financial measures in 2008 and 2010 that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as nonGAAP financial measures.</p>
<pre>
    

    --  adjusted earnings and earnings per share
    --  adjusted operating profit
    --  adjusted effective tax rate


    
</pre>
<p>These non-GAAP financial measures exclude certain items that are included in the company's earnings, earnings per share, operating profit and effective tax rate calculated in accordance with GAAP.  A detailed explanation of each of the adjustments to the comparable GAAP financial measures is given below.  In accordance with the SEC's requirements, reconciliations of the non-GAAP financial measures to the comparable GAAP financial measures are attached.</p>
<p/>
<p>The company provides these non-GAAP financial measures as supplemental information to our GAAP financial measures.  Management and the company's Board of Directors use adjusted earnings, adjusted earnings per share and adjusted operating profit to (a) evaluate the company's historical and prospective financial performance and its performance relative to its competitors, (b) allocate resources and (c) measure the operational performance of the company's business units and their managers.</p>
<p/>
<p>Additionally, the Management Development and Compensation Committee of the company's Board of Directors has used the non-GAAP financial measures related to the strategic cost reduction charges when setting and assessing achievement of incentive compensation goals.  These goals are based, in part, on the company's adjusted earnings per share and improvement in the company's adjusted return on invested capital determined by excluding the charges that are used in calculating these non-GAAP financial measures.</p>
<p/>
<p>In addition, Kimberly-Clark management believes that investors' understanding of the company's performance is enhanced by including these non-GAAP financial measures as a reasonable basis for comparing the company's ongoing results of operations.  Many investors are interested in understanding the performance of our businesses by comparing our results from ongoing operations from one period to the next.  By providing these non-GAAP financial measures, together with reconciliations, we believe we are enhancing investors' understanding of our businesses and our results of operations.  Also, many financial analysts who follow our company focus on and publish both historical results and future projections based on nonGAAP financial measures.  We believe that it is in the best interests of our investors for us to provide this information to analysts so that those analysts accurately report the non-GAAP financial information.</p>
<p/>
<p>We calculated adjusted earnings, adjusted earnings per share, adjusted operating profit and adjusted effective tax rate for the quarter and year ended <chron>December 31, 2008</chron> by excluding from the comparable GAAP measures charges related to our strategic cost reduction plan for streamlining the company's operations and an after-tax extraordinary loss related to the restructuring of certain contractual arrangements in the second quarter of 2008.  In addition, we will begin accounting for <location>Venezuela</location> as hyper-inflationary effective <chron>January 1, 2010</chron> and anticipate recording a one-time loss for the expected remeasurement of the local currency balance sheet in that country as a result of the recent currency devaluation.  We calculated estimated adjusted earnings per share and estimated adjusted effective tax rate for 2010 by excluding from the comparable GAAP measures the impacts of that loss.  The nature of and basis for the adjustments are described below:</p>
<p/>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
    --Strategic cost reduction plan. In July 2005, the company
     authorized a strategic cost reduction plan aimed at
     streamlining manufacturing and administrative operations,
     primarily in North America and Europe.  The strategic cost
     reduction plan commenced in the third quarter of 2005 and was
     completed as of December 31, 2008.  At the time we announced
     the plan, we advised investors that we would report our
     earnings, earnings per share and operating profit excluding
     the strategic cost reduction plan charges so that investors
     could compare our operating results without the plan charges
     from period to period and could assess our progress in
     implementing the plan.
          Management does not consider these charges to be part of our
           earnings from ongoing operations for purposes of evaluating
           the performance of its business units and their managers and
           excludes these charges when making decisions to allocate
           resources among its business units.
    -- Extraordinary loss.  In June 2008, the company
     restructured contractual arrangements of two financing
     entities, which resulted in the consolidation of these two
     entities.  As a result of the consolidation, notes receivable
     and loan obligations held by these entities have been included
     in long-term notes receivable and long-term debt on the
     company's consolidated balance sheet.  Because the fair value
     of the loans exceeded the fair value of the notes receivable,
     the company recorded an after-tax extraordinary loss on its
     income statement for the period ended June 30, 2008.
     Management does not consider this loss to be part of our
     earnings from ongoing operations for purposes of evaluating
     the performance of its business units and their managers and
     excludes this loss when making decisions to allocate resources
     among its business units.
    -- Devaluation of Venezuelan bolivar and hyper-inflationary
     accounting.  The company will begin accounting for Venezuela
     as hyper-inflationary effective January 1, 2010 and
     anticipates recording a loss in the first quarter 2010 for the
     expected remeasurement of the local currency balance sheet in
     Venezuela as a result of the recent currency devaluation.
     Management does not consider this loss to be part of our
     earnings from ongoing operations for the purposes of
     evaluating the performance of its business units and their
     managers and will exclude this loss when making decisions to
     allocate resources among its business units.
    --Adjusted effective tax rate. In the analysis of its
     effective tax rate, the company excludes the effects of
     charges for the strategic cost reduction plan and the
     estimated effect of the balance sheet remeasurement in
     Venezuela.  We believe that adjusting for these items provides
     improved insight into the tax effects of our ongoing business
     operations.



    
</pre>
<p>These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measure.  There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. The company compensates for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures.  The non-GAAP financial measures should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.</p>
<pre>
    

    Conference call

    
</pre>
<p>A conference call to discuss this news release and other matters of interest to investors and analysts will be held at <chron>9 a.m. (CST</chron>) today.  The conference call will be simultaneously broadcast over the World Wide Web.  Stockholders and others are invited to listen to the live broadcast or a playback, which can be accessed by following the instructions set out in the Investors section of the company's Web site (<a href="http://www.kimberly-clark.com">www.kimberly-clark.com</a>).</p>
<pre>
    

    About Kimberly-Clark

    
</pre>
<p>Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 150 countries.  Every day, 1.3 billion people - nearly a quarter of the world's population - trust K-C brands and the solutions they provide to enhance their health, hygiene and well-being.  With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds No. 1 or No. 2 share positions in more than 80 countries.  To keep up with the latest K-C news and to learn more about the company's 138-year history of innovation, visit <a href="http://www.kimberly-clark.com">www.kimberly-clark.com</a>.</p>
<p/>
<p>Copies of Kimberly-Clark's Annual Report to Stockholders and its proxy statements and other SEC filings, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, are made available free of charge on the company's Web site on the same day they are filed with the SEC.  To view these filings, visit the Investors section of the company's Web site.</p>
<p/>
<p>Certain matters contained in this news release concerning the business outlook, including economic conditions, anticipated currency rates and exchange risk, anticipated impact of acquisitions, cost savings, changes in finished product selling prices, anticipated raw material and energy costs, anticipated benefits related to the organization optimization initiative, anticipated financial and operating results, revenue realization strategies, contingencies and anticipated transactions of the company constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company.  There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated.  For a description of certain factors that could cause the company's future results to differ materially from those expressed in any such forward-looking statements, see Item 1A of the company's Annual Report on Form 10-K for the year ended <chron>December 31, 2008</chron> entitled "Risk Factors."</p>
<pre>
    



    
</pre>
<p> </p>
<pre>
    
               KIMBERLY-CLARK CORPORATION
             CONSOLIDATED INCOME STATEMENT
               PERIODS ENDED DECEMBER 31
    (Millions of dollars, except per share amounts)
    
</pre>
<p> </p>
<pre>
    
                                                  Three
                                                  Months
                                                  Ended
                                                 December
                                                         31
                                                    ---------
                                              2009             2008
                                              ----             ----
    
</pre>
<p> </p>
<pre>
    
    Net Sales                               $4,982           $4,598
        Cost of products sold                3,316            3,143
                                             -----            -----
    
</pre>
<p> </p>
<pre>
    
    Gross Profit                             1,666            1,455
        Marketing, research and general
         expenses                              974              817
    
</pre>
<p> </p>
<pre>
    
        Other (income) and expense, net        (25)              15
                                               ---              ---
    
</pre>
<p> </p>
<pre>
    
    Operating Profit                           717              623
        Interest income                          5               15
    
</pre>
<p> </p>
<pre>
    
        Interest expense                       (64)             (80)
                                               ---              ---
    
</pre>
<p> </p>
<pre>
    
    Income Before Income Taxes and
     Equity Interests                          658              558
    
</pre>
<p> </p>
<pre>
    
        Provision for income taxes            (184)            (125)
                                              ----             ----
    Income Before Equity Interests             474              433
        Share of net income of equity
         companies                              48               21
                                               ---              ---
    
</pre>
<p> </p>
<pre>
    
    Net Income                                 522              454
        Net income attributable to
         noncontrolling interests(a)           (30)             (35)
                                               ---              ---
    
</pre>
<p> </p>
<pre>
    
    Net Income Attributable to
     Kimberly-Clark Corporation(a)            $492             $419
                                              ====             ====
    
</pre>
<p> </p>
<p>Per Share Basis - Diluted</p>
<p> </p>
<pre>
    
        Net Income Attributable to
         Kimberly-Clark Corporation(a)       $1.17            $1.01
                                             =====            =====



    
</pre>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                                           Change
                                           ------
    
</pre>
<p> </p>
<pre>
    
    Net Sales                            +     8.4%
        Cost of products sold            +     5.5%
    
</pre>
<p> </p>
<pre>
    
    Gross Profit                          +   14.5%
        Marketing, research and general
         expenses                         +   19.2%
        Other (income) and expense, net      N.M.
    
</pre>
<p> </p>
<pre>
    
    Operating Profit                      +   15.1%
        Interest income                  -    66.7%
        Interest expense                 -    20.0%
    
</pre>
<p> </p>
<pre>
    
    Income Before Income Taxes and
     Equity Interests                     +   17.9%
        Provision for income taxes        +   47.2%
    Income Before Equity Interests       +     9.5%
        Share of net income of equity
         companies                         + 128.6%
    
</pre>
<p> </p>
<pre>
    
    Net Income                            +   15.0%
        Net income attributable to
         noncontrolling interests(a)     -    14.3%
    
</pre>
<p> </p>
<pre>
    
    Net Income Attributable to
     Kimberly-Clark Corporation(a)        +   17.4%
    
</pre>
<p> </p>
<p>Per Share Basis - Diluted</p>
<p> </p>
<pre>
    
        Net Income Attributable to
         Kimberly-Clark Corporation(a)    +   15.8%
    
</pre>
<p> </p>
<p> </p>
<pre>
    
    (a)   Effective January 1, 2009, the Corporation adopted new
    accounting requirements related to the presentation of
    noncontrolling interests in consolidated financial statements.
    Prior year amounts have been recast to conform to those
    requirements.
    
</pre>
<p> </p>
<pre>
    
    N.M. - Not meaningful
    Unaudited






    
</pre>
<p> </p>
<pre>
    
                                 KIMBERLY-CLARK CORPORATION
                                  PERIODS ENDED DECEMBER 31
                                    (Millions of dollars)
    
</pre>
<p> </p>
<pre>
    
    Notes:
    1. Charges for the Strategic Cost Reductions are included in the
    Consolidated Income Statement as follows:
    
</pre>
<p> </p>
<pre>
    
                                         Three Months
                                       Ended December 31
                                                         2008
                                                         ----
     Cost of products sold                                $12
    
</pre>
<p> </p>
<pre>
    
     Marketing, research and general
      expenses                                              8
    
</pre>
<p> </p>
<p> Other (income) and expense, net                      (14)</p>
<p> </p>
<pre>
    
     Provision for income taxes                            (6)
                                                          ---
    
</pre>
<p> </p>
<pre>
    
     Net charges                     $                      -





    
</pre>
<p> </p>
<pre>
    
    2. Organization optimization charges are included in the Consolidated
    Income Statement as follows:
    
</pre>
<p> </p>
<pre>
    
                                       Three Months
                                     Ended December 31
                                                       2009
                                                       ----
     Cost of products sold                               $3
    
</pre>
<p> </p>
<pre>
    
     Marketing, research and general
      expenses                                            3
    
</pre>
<p> </p>
<p> Provision for income taxes                          (2)</p>
<p> </p>
<p> </p>
<p> Net charges                                         <money>$4</money></p>
<p> </p>
<p> </p>
<pre>
    
    Unaudited



    
</pre>
<p> </p>
<pre>
    
               KIMBERLY-CLARK CORPORATION
             CONSOLIDATED INCOME STATEMENT
               PERIODS ENDED DECEMBER 31
    (Millions of dollars, except per share amounts)
    
</pre>
<p> </p>
<pre>
    
                                              Twelve
                                              Months
                                               Ended
                                             December
                                                    31
                                                 ---------
                                               2009              2008
                                               ----              ----
    
</pre>
<p> </p>
<pre>
    
    Net Sales                               $19,115           $19,415
        Cost of products sold                12,695            13,557
                                             ------            ------
    
</pre>
<p> </p>
<pre>
    
    Gross Profit                              6,420             5,858
        Marketing, research and general
         expenses                             3,498             3,291
        Other (income) and expense, net          97                20
                                                ---               ---
    
</pre>
<p> </p>
<pre>
    
    Operating Profit                          2,825             2,547
        Interest income                          26                46
        Interest expense                       (275)             (304)
                                               ----              ----
    
</pre>
<p> </p>
<pre>
    
    Income Before Income Taxes,
     Equity Interests and
     Extraordinary Loss                       2,576             2,289
        Provision for income taxes             (746)             (618)
                                               ----              ----
    Income Before Equity Interests
     and Extraordinary Loss                   1,830             1,671
        Share of net income of equity
         companies                              164               166
        Extraordinary loss, net of
         income taxes                             -                (8)
                                                ---               ---
    
</pre>
<p> </p>
<pre>
    
    Net Income                                1,994             1,829
        Net income attributable to
         noncontrolling interests(a)           (110)             (139)
                                               ----              ----
    
</pre>
<p> </p>
<pre>
    
    Net Income Attributable to
     Kimberly-Clark Corporation(a)           $1,884            $1,690
                                             ======            ======
    
</pre>
<p> </p>
<p>Per Share Basis - Diluted</p>
<p> </p>
<pre>
    
        Before extraordinary loss             $4.52             $4.05
                                              -----             -----
    
</pre>
<p> </p>
<pre>
    
        Net Income Attributable to
         Kimberly-Clark Corporation(a)        $4.52             $4.03
                                              =====             =====



    
</pre>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                                           Change
                                           ------
    
</pre>
<p> </p>
<pre>
    
    Net Sales                            -    1.5%
        Cost of products sold            -    6.4%
    
</pre>
<p> </p>
<pre>
    
    Gross Profit                          +   9.6%
        Marketing, research and general
         expenses                         +   6.3%
        Other (income) and expense, net      N.M.
    
</pre>
<p> </p>
<pre>
    
    Operating Profit                       + 10.9%
        Interest income                   -  43.5%
        Interest expense                 -    9.5%
    
</pre>
<p> </p>
<pre>
    
    Income Before Income Taxes,
     Equity Interests and
     Extraordinary Loss                    + 12.5%
        Provision for income taxes         + 20.7%
    Income Before Equity Interests
     and Extraordinary Loss               +   9.5%
        Share of net income of equity
         companies                       -    1.2%
        Extraordinary loss, net of
         income taxes                        N.M.
    
</pre>
<p> </p>
<pre>
    
    Net Income                            +   9.0%
        Net income attributable to
         noncontrolling interests(a)      -  20.9%
    
</pre>
<p> </p>
<pre>
    
    Net Income Attributable to
     Kimberly-Clark Corporation(a)         + 11.5%
    
</pre>
<p> </p>
<p>Per Share Basis - Diluted</p>
<p> </p>
<p>    Before extraordinary loss          + 11.6%</p>
<p> </p>
<pre>
    
        Net Income Attributable to
         Kimberly-Clark Corporation(a)     + 12.2%
    
</pre>
<p> </p>
<p> </p>
<pre>
    
    (a)   Effective January 1, 2009, the Corporation adopted new
    accounting requirements related to the presentation of
    noncontrolling interests in consolidated financial statements.
    Prior year amounts have been recast to conform to those
    requirements.
    
</pre>
<p> </p>
<pre>
    
    N.M. - Not meaningful
    Unaudited





    
</pre>
<p> </p>
<pre>
    
                                 KIMBERLY-CLARK CORPORATION
                                  PERIODS ENDED DECEMBER 31
                       (Millions of dollars, except per share amounts)
    
</pre>
<p> </p>
<pre>
    
    Notes:
    1. Charges for the Strategic Cost Reductions are included in the
    Consolidated Income Statement as follows:
    
</pre>
<p> </p>
<pre>
    
                                       Twelve Months
                                     Ended December 31
                                                       2008
                                                       ----
     Cost of products sold                              $43
    
</pre>
<p> </p>
<pre>
    
     Marketing, research and general
      expenses                                           29
    
</pre>
<p> </p>
<p> Other (income) and expense, net                    (12)</p>
<p> </p>
<pre>
    
     Provision for income taxes                         (24)
                                                        ---
    
</pre>
<p> </p>
<pre>
    
     Net charges                                        $36



    
</pre>
<p> </p>
<pre>
    
    2. Organization optimization charges are included in the Consolidated
    Income Statement as follows:
    
</pre>
<p> </p>
<pre>
    
                                                Twelve Months
                                              Ended December 31
                                                                2009
                                                                ----
     Cost of products sold                                       $44
    
</pre>
<p> </p>
<p> Marketing, research and general expenses                     84</p>
<p> </p>
<pre>
    
     Provision for income taxes                                  (37)
                                                                 ---
    
</pre>
<p> </p>
<pre>
    
     Net charges                                                 $91



    
</pre>
<p> </p>
<p>3. Other information:</p>
<p> </p>
<pre>
    
                                                         Twelve Months
                                                         Ended December
                                                                 31
                                                          ---------------
                                                        2009          2008
                                                        ----          ----
              Cash Dividends Declared Per Share        $2.40         $2.32


    
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                                                           December 31
                                                           -----------
              Common Shares (Millions)                  2009           2008
                                                        ----           ----
    
</pre>
<p> </p>
<p>          Outstanding, as of                       416.9          413.6</p>
<p> </p>
<pre>
    
              Average Diluted for:
                Three Months Ended                     419.2          416.3
                Twelve Months Ended                    416.8          419.6
    
</pre>
<p> </p>
<p> </p>
<pre>
    
    Unaudited




    
</pre>
<p> </p>
<pre>
    
                              KIMBERLY-CLARK CORPORATION
                               PERIODS ENDED DECEMBER 31
                                 (Millions of dollars)
    Supplemental Financial Information:
    
</pre>
<p> </p>
<pre>
    
    Preliminary Balance Sheet Data:
    -------------------------------
                                                  December  December
                                                     31       31
                                                       2009    2008
                                                       ----    ----
    
</pre>
<p> </p>
<p>Cash and cash equivalents                          <money>$798</money>    <money>$364</money></p>
<p> </p>
<p>Accounts receivable, net                          2,554   2,492</p>
<p> </p>
<p>Inventories                                       2,033   2,493</p>
<p> </p>
<p>Total current assets                              5,850   5,813</p>
<p> </p>
<p>Total assets                                     19,182  18,089</p>
<p> </p>
<p>Accounts payable                                  1,920   1,603</p>
<p> </p>
<p>Debt payable within one year                        610   1,083</p>
<p> </p>
<p>Total current liabilities                         4,910   4,752</p>
<p> </p>
<p>Long-term debt                                    4,792   4,882</p>
<p> </p>
<pre>
    
    Redeemable preferred and common securities of
     subsidiaries                                     1,052   1,032
    
</pre>
<p> </p>
<pre>
    
    Stockholders' equity                              5,696   4,261


    
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                                          Twelve Months
                                        Ended December 31
                                        -----------------
    Preliminary Cash Flow Data:          2009              2008
    ---------------------------          ----              ----
    
</pre>
<p> </p>
<pre>
    
    Cash provided by operations        $3,481            $2,516
                                       ======            ======
    
</pre>
<p> </p>
<pre>
    
    Cash used for investing           $(1,288)            $(847)
                                      =======             =====
    
</pre>
<p> </p>
<pre>
    
    Cash used for financing           $(1,788)          $(1,747)
                                      =======           =======
    
</pre>
<p> </p>
<pre>
    
        Depreciation and amortization    $783              $775
                                         ====              ====
    
</pre>
<p> </p>
<pre>
    
        Capital spending                 $848              $906
                                         ====              ====
    
</pre>
<p> </p>
<pre>
    
        Cash dividends paid              $986              $950
                                         ====              ====
    
</pre>
<p> </p>
<p> </p>
<pre>
    
    Unaudited



    
</pre>
<p> </p>
<p> </p>
<pre>
    
                              KIMBERLY-CLARK CORPORATION
                               PERIODS ENDED DECEMBER 31


    Description of Business Segments

    
</pre>
<p>The Corporation is organized into operating segments based on product groupings. These operating segments have been aggregated into four reportable global business segments:  Personal Care; Consumer Tissue; K-C Professional & Other; and Health Care. The reportable segments were determined in accordance with how the Corporation's executive managers develop and execute the Corporation's global strategies to drive growth and profitability of the Corporation's worldwide Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care operations. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes other income and (expense), net; income and expense not associated with the business segments; and the costs of corporate decisions related to the Strategic Cost Reductions.  Corporate & Other includes the costs related to the Strategic Cost Reductions.</p>
<p/>
<p>The principal sources of revenue in each of our global business segments are described below.</p>
<p/>
<p>The Personal Care segment manufactures and markets disposable diapers, training and youth pants and swimpants; baby wipes; feminine and incontinence care products; and related products. Products in this segment are primarily for household use and are sold under a variety of brand names, including Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, Lightdays, Depend, Poise and other brand names.</p>
<p/>
<p>The Consumer Tissue segment manufactures and markets facial and bathroom tissue, paper towels, napkins and related products for household use. Products in this segment are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, Page and other brand names.</p>
<p/>
<p>The K-C Professional & Other segment manufactures and markets facial and bathroom tissue, paper towels, napkins, wipers and a range of safety products for the away-from-home marketplace. Products in this segment are sold under the Kimberly-Clark, Kleenex, Scott, WypAll, Kimtech, KleenGuard, Kimcare and <location>Jackson</location> brand names.</p>
<p/>
<p>The Health Care segment manufactures and markets disposable health care products such as surgical gowns, drapes, infection control products, sterilization wrap, face masks, exam gloves, respiratory products and other disposable medical products.  Products in this segment are sold under the Kimberly-Clark, Ballard, ON-Q and other brand names.</p>
<pre>
    

    Unaudited



    
</pre>
<p> </p>
<pre>
    
                                              KIMBERLY-CLARK CORPORATION
                                            SELECTED BUSINESS SEGMENT DATA
                                               PERIODS ENDED DECEMBER 31
                                                 (Millions of dollars)
    
</pre>
<p> </p>
<pre>
    
                                                    Three Months
                                                 Ended December 31
                                                 -----------------
                                            2009          2008      Change
                                            ----          ----      ------
    NET SALES:
    
</pre>
<p> </p>
<pre>
    
    Personal Care                         $2,134        $1,914       + 11.5%
    Consumer Tissue                        1,655         1,640      +   0.9%
    K-C Professional & Other                 815           730       + 11.6%
    Health Care                              387           317       + 22.1%
    
</pre>
<p> </p>
<p>Corporate & Other                         15            17       N.M.</p>
<p> </p>
<pre>
    
    Intersegment Sales                       (24)          (20)      N.M.
                                             ---           ---
    
</pre>
<p> </p>
<pre>
    
    Consolidated                          $4,982        $4,598      +   8.4%
                                          ======        ======
    
</pre>
<p> </p>
<p>OPERATING PROFIT(a):</p>
<p> </p>
<pre>
    
    Personal Care                           $436          $380       + 14.7%
    Consumer Tissue                          149           182      -  18.1%
    K-C Professional & Other                 119           101       + 17.8%
    Health Care                               56            45       + 24.4%
    
</pre>
<p> </p>
<p>Corporate & Other(b)                     (68)          (70)    -    2.9%</p>
<p> </p>
<pre>
    
    Other income and (expense), net(b)(c)     25           (15)      N.M.
                                             ---           ---
    
</pre>
<p> </p>
<pre>
    
    Consolidated                            $717          $623       + 15.1%
                                            ====          ====



    
</pre>
<p> </p>
<p> </p>
<pre>
    
                                                  Twelve Months
                                                Ended December 31
                                                -----------------
                                             2009            2008   Change
                                             ----            ----   ------
    NET SALES:
    
</pre>
<p> </p>
<pre>
    
    Personal Care                          $8,365          $8,272   +   1.1%
    Consumer Tissue                         6,409           6,748  -    5.0%
    K-C Professional & Other                3,007           3,174  -    5.3%
    Health Care                             1,371           1,224    + 12.0%
    
</pre>
<p> </p>
<p>Corporate & Other                          53              79    N.M.</p>
<p> </p>
<pre>
    
    Intersegment Sales                        (90)            (82)   N.M.
                                              ---             ---
    
</pre>
<p> </p>
<pre>
    
    Consolidated                          $19,115         $19,415  -    1.5%
                                          =======         =======
    
</pre>
<p> </p>
<p>OPERATING PROFIT(a):</p>
<p> </p>
<pre>
    
    Personal Care                          $1,739          $1,649   +   5.5%
    Consumer Tissue                           736             601    + 22.5%
    K-C Professional & Other                  464             428   +   8.4%
    Health Care                               244             143    + 70.6%
    
</pre>
<p> </p>
<p>Corporate & Other(b)                     (261)           (254)  +   2.8%</p>
<p> </p>
<pre>
    
    Other income and (expense), net(b)(c)     (97)            (20)   N.M.
                                              ---             ---
    
</pre>
<p> </p>
<pre>
    
    Consolidated                           $2,825          $2,547    + 10.9%
                                           ======          ======
    
</pre>
<p> </p>
<p> </p>
<pre>
    
    (a)  Organization optimization charges in 2009 are included by
    business segment as follows:



    
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                              Three Months  Twelve Months
                             Ended December Ended December
                                   31             31
                                       2009           2009
                                       ----           ----
    
</pre>
<p> </p>
<pre>
    
    Personal Care                        $3            $47
    Consumer Tissue                       3             50
    K-C Professional & Other                            16
    Health Care                           -              6
    Corporate & Other                                    9
                                        ---
      Total                              $6           $128
                                                      ====
    
</pre>
<p> </p>
<p> </p>
<pre>
    
    N.M. - Not meaningful
    Unaudited





    
</pre>
<p> </p>
<pre>
    
                            KIMBERLY-CLARK CORPORATION
                          SELECTED BUSINESS SEGMENT DATA
                             PERIODS ENDED DECEMBER 31
    
</pre>
<p> </p>
<pre>
    
    (b)  Corporate & Other and Other income and (expense), net, include
    the following amounts of pre-tax charges for the strategic cost
    reductions.
    
</pre>
<p> </p>
<pre>
    
                                     Three Months    Twelve Months
                                    Ended December   Ended December
                                           31              31
                                               2008            2008
                                               ----            ----
    Corporate & Other                          $(20)           $(72)
    
</pre>
<p> </p>
<p>Other income and (expense), net              14              12</p>
<p> </p>
<p> </p>
<pre>
    
    (c)  Other income and (expense), net, includes the following amounts
    of currency transaction losses.



    
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                        Three Months           Twelve Months
                      Ended December 31        Ended December 31
                      -----------------        -----------------
                     2009               2008   2009              2008
                     ----               ----   ----              ----
    
</pre>
<p> </p>
<pre>
    
    Other income and
     (expense), net   $(1)              $(20) $(110)             $(18)



    
</pre>
<p> </p>
<p>PERCENTAGE CHANGE IN NET SALES VERSUS PRIOR YEAR</p>
<p> </p>
<pre>
    
                                Three Months Ended December 31, 2009
                                ------------------------------------
                                        Organic         Acquisition   Total
                                Total   Volume           Volume(1)   Volume
                                -----   ------           ---------   ------
    
</pre>
<p> </p>
<p>Consolidated                   8.4        2                   1        3</p>
<p> </p>
<p>   Personal Care              11.5        5                   -        5</p>
<p> </p>
<p>   Consumer Tissue             0.9       (2)                  -       (2)</p>
<p> </p>
<p>   K-C Professional & Other   11.6       (3)                  3        -</p>
<p> </p>
<pre>
    
       Health Care                22.1       13                   6       19



    
</pre>
<p> </p>
<p> </p>
<pre>
    
                                Three Months Ended December 31, 2009
                                ------------------------------------
                                  Net             Mix/
                                 Price          Other(2)          Currency
                                 -----          --------          --------
    
</pre>
<p> </p>
<p>Consolidated                      2                (2)               5</p>
<p> </p>
<p>   Personal Care                  2                (1)               5</p>
<p> </p>
<p>   Consumer Tissue               (1)                -                4</p>
<p> </p>
<p>   K-C Professional & Other       7                 -                5</p>
<p> </p>
<pre>
    
       Health Care                    -                 -                3


    
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                                Twelve Months Ended December 31, 2009
                                -------------------------------------
                                                Organic
                                 Total          Volume
                                 -----          ------
    
</pre>
<p> </p>
<p>Consolidated                   (1.5)             (1)</p>
<p> </p>
<p>   Personal Care                1.1               2</p>
<p> </p>
<p>   Consumer Tissue             (5.0)             (3)</p>
<p> </p>
<p>   K-C Professional & Other    (5.3)             (8)</p>
<p> </p>
<pre>
    
       Health Care                 12.0              12



    
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                                Twelve Months Ended December 31, 2009
                                -------------------------------------
                                 Acquisition          Total
                                  Volume(1)          Volume
                                  ---------          ------
    
</pre>
<p> </p>
<p>Consolidated                           -              (1)</p>
<p> </p>
<p>   Personal Care                       -               2</p>
<p> </p>
<p>   Consumer Tissue                     -              (3)</p>
<p> </p>
<p>   K-C Professional & Other            2              (6)</p>
<p> </p>
<pre>
    
       Health Care                         2              14



    
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
    
                                Twelve Months Ended December 31, 2009
                                -------------------------------------
                                  Net             Mix/
                                 Price          Other(2)          Currency
                                 -----          --------          --------
    
</pre>
<p> </p>
<p>Consolidated                      4                 -               (5)</p>
<p> </p>
<p>   Personal Care                  5                 -               (6)</p>
<p> </p>
<p>   Consumer Tissue                3                 -               (5)</p>
<p> </p>
<p>   K-C Professional & Other       4                 1               (4)</p>
<p> </p>
<p>   Health Care                    -                 -               (2)</p>
<p> </p>
<p> </p>
<pre>
    
    (1)Volume related to Jackson Safety and I-Flow acquisitions.
    (2) Mix/Other includes rounding.




    
</pre>
<p> </p>
<pre>
    
                          KIMBERLY-CLARK CORPORATION
                          PERIODS ENDED DECEMBER 31
               (Millions of dollars, except per share amounts)
    
</pre>
<p> </p>
<p>NON-GAAP RECONCILIATION SCHEDULES</p>
<p> </p>
<pre>
    
    The tables on the following pages present the reconciliation of non-
    GAAP financial measures to GAAP financial measures.
    
</pre>
<p> </p>
<p>EARNINGS SUMMARY:</p>
<p> </p>
<pre>
    
                                                Three
                                               Months
                                                Ended
                                              December
                                              31, 2008
                                                  --------
                                                         Diluted
                                         Income          Earnings
                                                             Per
                                         (Expense)                Share
                                         ---------         ------
    
</pre>
<p> </p>
<p>Adjusted Earnings                       <money>$419</money>            <money>$1.01</money></p>
<p> </p>
<p>Adjustments for:</p>
<p> </p>
<pre>
    
       Strategic Cost Reduction
        charges                                -                -
    
</pre>
<p> </p>
<p>   Extraordinary Loss                      -                -</p>
<p> </p>
<pre>
    
    Rounding                                   -                -
                                             ---              ---
    
</pre>
<p> </p>
<pre>
    
    Net Income Attributable to
     Kimberly-Clark Corporation             $419            $1.01
                                            ====            =====



    
</pre>
<p> </p>
<p> </p>
<pre>
    
                                                 Twelve
                                                 Months
                                                 Ended
                                                December
                                                31, 2008
                                                   --------
                                                          Diluted
                                          Income          Earnings
                                                             Per
                                         (Expense)                  Share
                                         ---------         ------
    
</pre>
<p> </p>
<p>Adjusted Earnings                       <money>$1,734</money>            <money>$4.13</money></p>
<p> </p>
<p>Adjustments for:</p>
<p> </p>
<pre>
    
       Strategic Cost Reduction
        charges                                (36)            (.09)
    
</pre>
<p> </p>
<p>   Extraordinary Loss                       (8)            (.02)</p>
<p> </p>
<pre>
    
    Rounding                                     -              .01
                                               ---              ---
    
</pre>
<p> </p>
<pre>
    
    Net Income Attributable to
     Kimberly-Clark Corporation             $1,690            $4.03
                                            ======            =====



    
</pre>
<p> </p>
<p>OPERATING PROFIT SUMMARY:</p>
<p> </p>
<pre>
    
                                         Three Months     Twelve Months
                                        Ended December
                                              31        Ended December 31
                                                  2008               2008
                                                  ----               ----
    
</pre>
<p> </p>
<p>Adjusted Operating Profit                     <money>$629</money>             <money>$2,607</money></p>
<p> </p>
<p>Adjustments for:</p>
<p> </p>
<pre>
    
       Strategic Cost Reduction charges             (6)               (60)
                                                                      ---
    
</pre>
<p> </p>
<pre>
    
    Operating Profit                              $623             $2,547
                                                  ====             ======



    
</pre>
<p> </p>
<pre>
    
    EFFECTIVE INCOME TAX RATE RECONCILIATION: Adjustments for Strategic
    Cost Reduction charges
    
</pre>
<p> </p>
<pre>
    
                                               Three
                                              Months
                                               Ended
                                             December
                                             31, 2008
                                                 --------
                                         As            Excluding
                                       Reported         Adjustments
                                       --------         -----------
    
</pre>
<p> </p>
<p>Income Before Income Taxes             <money>$558</money>             <money>$564</money></p>
<p> </p>
<p>Provision for Income Taxes              125              131</p>
<p> </p>
<p>Effective Income Tax Rate              22.4%</p>
<p> </p>
<pre>
    
    Adjusted Effective Income Tax
     Rate                                                   23.2%



    
</pre>
<p> </p>
<p> </p>
<pre>
    
                                              Twelve
                                              Months
                                               Ended
                                             December
                                             31, 2008
                                                 --------
                                         As            Excluding
                                       Reported         Adjustments
                                       --------         -----------
    
</pre>
<p> </p>
<p>Income Before Income Taxes           <money>$2,289</money>           <money>$2,349</money></p>
<p> </p>
<p>Provision for Income Taxes              618              642</p>
<p> </p>
<p>Effective Income Tax Rate              27.0%</p>
<p> </p>
<pre>
    
    Adjusted Effective Income Tax
     Rate                                                   27.3%




    
</pre>
<p> </p>
<pre>
    
                  KIMBERLY-CLARK CORPORATION
                  PERIODS ENDED DECEMBER 31
    
</pre>
<p> </p>
<p> </p>
<p>OUTLOOK FOR 2010</p>
<p> </p>
<p>Estimated Full-Year 2010 Diluted Earnings Per Share:</p>
<p> </p>
<p>Adjusted Earnings Per Share           <money>$4.80</money>     -      <money>$5.00</money></p>
<p> </p>
<pre>
    
    Adjustment for Venezuelan
     Balance Sheet Remeasurement           (.22)    -       (.14)
                                           ----             ----
    
</pre>
<p> </p>
<pre>
    
    Earnings Per Share - Diluted          $4.58     -      $4.86
                                          =====            =====



    
</pre>
<p> </p>
<p>Estimated Full-Year 2010 Effective Tax Rate:</p>
<p> </p>
<p>Adjusted Effective Tax Rate            29%    -       31%</p>
<p> </p>
<pre>
    
    Adjustment for Venezuelan
     Balance Sheet Remeasurement            1%    -        1%
                                          ---            ---
    
</pre>
<p> </p>
<pre>
    
    Effective Tax Rate                     30%    -       32%
                                          ===            ===






    

For further information: For further information: Investors, Paul Alexander, +1-972-281-1440, palexand@kcc.com, or Media, Kay Jackson, +1-972-281-1486, kay.jackson@kcc.com, both of Kimberly-Clark Corporation Web Site: http://www.kimberly-clark.com

Organization Profile

Kimberly-Clark

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890